Bexagliflozin
Drug Details
- Generic Name
- Bexagliflozin
- Brand Names
- Bexagliflozin, BRENZAVVY
- Application Number
- NDA214373
- Sponsor
- TheracosBio, LLC
- NDC Codes
- 4
- Dosage Forms
- TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- BEXAGLIFLOZIN
Indications and Usage
1 INDICATIONS AND USAGE Bexagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Bexagliflozin is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. [see Warnings and Precautions ( 5.1 )] . Bexagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitation of Use: Not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. ( 1 )